Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy (CADASIL) is the prototypical monogenic cerebral small vessel disease caused by pathogenic variants in NOTCH3. Despite its well-established genetic basis, CADASIL ex-hibits substantial clinical, radiological, and biological heterogeneity, indicating that dis-ease expression is shaped by interactions between the causal variant and additional ge-netic, epigenetic, sex-related, and environmental modifiers. This review provides an inte-grative overview of CADASIL pathogenesis, from NOTCH3 structure and signaling ab-normalities to vascular dysfunction and cerebral injury. We examine genotype–phenotype relationships, including the effects of variant location and non-canonical variants, and discuss the potential contribution of modifier loci, vascular risk factors, and sex-specific mechanisms. Emerging evidence implicates vascular smooth muscle cell dysfunction, endoplasmic reticulum and oxidative stress, inflammation, complement activation, ex-tracellular-matrix remodeling, and alterations of the neurovascular unit in disease pro-gression. We further evaluate genetic, structural, physiological, and molecular biomarkers, highlighting the potential of multimodal approaches to characterize disease burden, iden-tify early vascular dysfunction, and improve patient stratification. Finally, we discuss current supportive and preventive management alongside emerging therapeutic strategies targeting NOTCH3 production and processing, extracellular protein accumulation, vas-cular-cell dysfunction, and downstream pathological pathways. Although precision medicine in CADASIL remains primarily focused on integrated diagnosis and phenotyp-ing, advances in patient-specific models, biomarker development, and mecha-nism-informed interventions provide a framework for future therapeutic development. A better understanding of disease modifiers and pathogenic pathways will be essential to improve prognostic assessment and advance individualized management.